ISPOR’s ViHRI Call for Papers

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2ajcPih on July 29, 2016 at 12:25PM  (ISPOR) region-specific scientific peer-reviewed journal, Value in Health Regional Issues (ViHRI) is currently inviting manuscript submissions on health policy analysis, original health care research and other health related topics. More information on content and submission deadlines here. (Source: ISPOR, 2016)

3 Key Concepts of the New PhRMA and BIO Principles

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2afhfZj on July 29, 2016 at 09:24AM Patients, caregivers, health care professionals and insurers are demanding more information about safety, effectiveness and value of treatments, however, the regulatory framework governing this information needs to be modernized to reflect the rapidly evolving science and increased pace of the development […]

ARM 2016: Moving evidence into action

from AcademyHealth Blog at http://bit.ly/2aByasQ on July 29, 2016 at 07:06AM Health services research produces evidence that can have a transformative effect on healthcare quality and value, but the real promise of this information is in what happens after the research project ends. Moving knowledge into policy and practice is a key component of AcademyHealth’s […]

British immigration: more time combating clandestine immigrants means less time investigating scams

from Market Design at http://bit.ly/2aeRJ6l on July 29, 2016 at 06:35AM What do immigration inspectors do? The Telegraph has the story: Overwhelmed border guards diverted from other immigration scams to deal with threefold increase in migrants arriving by lorry and Channel Tunnel “It’s worrying that problems at the border meant that that organised crime and sham […]

Friday Links

from Healthcare Economist at http://bit.ly/2agqpZC on July 28, 2016 at 10:23PM Progress in the fight against pancreatic cancer? Pouring billions down the drain? Does calorie labeling work? When life gives you MACRA. A one size fits all formulary policy?

When Life Gives you MACRA…

from THCB at http://bit.ly/2azq9oc on July 28, 2016 at 12:57PM By LEONARD D’AVOLIO I was walking with colleagues debating the merits of the latest round of healthcare payment reforms when we came across the ultimate symbol of American entrepreneurialism.  A young girl had set up a lemonade stand with a sign marketing 25 cents a […]

Refugees from Central America

from Market Design at http://bit.ly/2adpO66 on July 28, 2016 at 06:46AM The NY times has the story: "The White House on Tuesday announced a substantial expansion of a program to admit Central American refugees to the United States, conceding that its efforts to protect migrants fleeing dangerous conditions had left too many people with no […]

Can physicians affect medication adherence?

from Healthcare Economist at http://bit.ly/2aM0FAe on July 28, 2016 at 12:50AM Can physicians affect medication adherence? Written By: Jason Shafrin – Jul• 27•16 According to a recent study by Koulayev, Simeonova, and Skipper (2016) using data from Denmark, the answer is ‘yes’. Non-compliance with medication therapy remains an unsolved and expensive problem for healthcare systems […]

Should we just abandon p-values altogether?

from The Academic Health Economists’ Blo… at http://bit.ly/2abBJRZ on July 28, 2016 at 12:30AM P-values do not indicate whether a scientific finding is true. Statistical significance does not equal economic or clinical significance. And p-values are often presented for tests that have no bearing on the questions being posed. So what’s the point? Empirical economics […]

Using Simulation to Model and Validate Invasive Breast Cancer Progression in Women in the Study and Control Groups of the Canadian National Breast Screening Studies I and II

from Medical Decision Making RSS feed at http://bit.ly/2adknc9 on July 27, 2016 at 11:15PM Background. Modeling breast cancer progression and the effect of various risk is helpful in deciding when a woman should start and end screening, and how often the screening should be undertaken. Methods. We modeled the natural progression of breast cancer using […]

euroqol group funding

from Terry Flynn PhD at http://bit.ly/2aKXzMO on July 27, 2016 at 02:19PM Sander Arons, Karin Oudshoorn and I have a EuroQoL funded project: how a *correctly* designed Case 2 best-worst scaling (BWS) study + a DCE can give us a tariff for EQ-5D-5L. The study will be interesting as we work from first principles: what […]